Nobivac Myxo-RHD Plus

Nobivac Myxo-RHD Plus is a vaccine used in rabbits to reduce death and clinical signs due to myxomatosis and rabbit haemorrhagic disease (RHD). Myxomatosis is caused by the myxoma virus and is spread between rabbits by close contact and biting insects such as fleas and mosquitoes. The virus causes swelling and discharge from the eyes, nose and bottom with most rabbits dying within 10 – 14 days. RHD, caused by classical RHD virus (RHDV1) and RHD type 2 virus (RHDV2), leads to blood clots in major organs such as the heart, lungs and kidneys leading to heart and respiratory failure when the heart and lungs do not work properly. Nobivac Myxo-RHD Plus contains live myxoma vectored RHD virus strains 009 and MK1899.

Nobivac Myxo-RHD Plus is a new vaccine developed to reduce death in rabbits, as well as clinical signs of myxomatosis and rabbit haemorrhagic disease (RHD).

Myxomatosis is caused by the myxoma virus and is spread between rabbits in close contact with one another, as well as by biting insects such as fleas and mosquitoes. The virus causes swelling and discharge from the eyes, nose and bottom and has a very poor prognosis, with most rabbits dying within 10 – 14 days.

RHD, caused by the RHD virus (RHDV1) and RHD type 2 virus (RHDV2), leads to blood clots in major organs such as the heart and lungs. This subequently leads to heart and respiratory failure when the heart and lungs stop working. Nobivac Myxo-RHD Plus contains live myxoma vectored RHD virus strains 009 and MK1899.

Rabbits used to have two injections per year in order to protect against myxo/RHDV1 and RHDV2. This new vaccine contains everything combined in one vial, so rabbits would only require once yearly vaccines if Nobivac Myxo-RHD Plus is used.